Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
about
A Review of Safety and Design Requirements of the Artificial Pancreas.Parental evaluation of a telemonitoring service for children with Type 1 Diabetes.The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.Is Psychological Stress a Factor for Incorporation Into Future Closed-Loop Systems?Identification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.A physiology-based model describing heterogeneity in glucose metabolism: the core of the Eindhoven Diabetes Education Simulator (E-DES)Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?Psychological Reactions Associated With Continuous Glucose Monitoring in Youth.Remote Blood Glucose Monitoring in mHealth Scenarios: A ReviewPhysical activity and type 1 diabetes: time for a rewire?The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges.Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas.Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.
P2860
Q28066687-56C400CE-A66B-441A-977F-63906A86136AQ30252858-E54DDA45-9E4C-47F8-8B0E-2A4D6F179C1FQ30276534-292E9B96-E33A-49F8-A578-B0FF357C6D9DQ30277161-6A7D7D73-EB22-46E3-9E9B-36C40DE70A66Q30278498-218D8208-58E5-4EB7-9241-661C0FCAA3D4Q30278964-53E484D6-5403-41FF-942B-0325F374ECE7Q30300933-6CC8F311-E7A5-4B73-854E-CF74436D993AQ36159163-EE929428-4006-4864-9000-86367E8AE450Q36340392-C0B222E2-7729-4AB8-A194-C35AFCF88677Q37288511-96D9943D-43D6-4EE8-BD93-ABC3D6BC99C1Q37288556-0D2BC40E-ABEE-483B-9601-10FEE7CBC4B1Q37537150-E09C28BB-97BA-43F2-9DA4-91CBA69F8C45Q38310888-BA0EEEB9-DF11-4F80-9884-F21D8D7127DEQ39413453-9E527604-FCFB-4D61-A737-F5C02C0045BBQ48123950-16AE6F83-4539-42BA-86FF-466459E4F698Q51654262-F092A722-EA69-443E-8713-BAE705F8CE3DQ53396068-1E2FDF00-3A3F-4EBF-B328-56B4BEBA62B8
P2860
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multicenter closed-loop insuli ...... 1 diabetes from various sites.
@ast
Multicenter closed-loop insuli ...... 1 diabetes from various sites.
@en
type
label
Multicenter closed-loop insuli ...... 1 diabetes from various sites.
@ast
Multicenter closed-loop insuli ...... 1 diabetes from various sites.
@en
prefLabel
Multicenter closed-loop insuli ...... 1 diabetes from various sites.
@ast
Multicenter closed-loop insuli ...... 1 diabetes from various sites.
@en
P2093
P2860
P50
P356
P1476
Multicenter closed-loop insuli ...... 1 diabetes from various sites.
@en
P2093
Alessio Filippi
Angelo Avogaro
Anne Farret
Boris Kovatchev
Bruce A Buckingham
Chiara Toffanin
Control to Range Study Group
Davide Martino Raimondo
Eran Atlas
Eric Renard
P2860
P304
P356
10.1089/DIA.2014.0066
P577
2014-07-08T00:00:00Z